|
Volumn 12, Issue 17, 2002, Pages 2381-2386
|
Potential anxiolytic agents. Part 4: Novel orally-active N5-substituted pyrido[1,2-a]benzimidazoles with high GABA-A receptor affinity
|
Author keywords
[No Author keywords available]
|
Indexed keywords
4 AMINOBUTYRIC ACID A RECEPTOR;
ALKYL GROUP;
ANXIOLYTIC AGENT;
BENZIMIDAZOLE DERIVATIVE;
BENZODIAZEPINE;
METHYL GROUP;
NITROGEN;
PYRIDINE DERIVATIVE;
ARTICLE;
BINDING AFFINITY;
CONTROLLED STUDY;
DRUG SYNTHESIS;
EVALUATION;
HUMAN;
IC 50;
RECEPTOR AFFINITY;
TRANQUILIZING ACTIVITY;
ANIMAL;
BRAIN CORTEX;
CHEMICALLY INDUCED DISORDER;
CONFLICT;
DRUG EFFECT;
DRUG POTENTIATION;
METABOLISM;
MOUSE;
ORAL DRUG ADMINISTRATION;
PROTEIN BINDING;
RAT;
SEIZURE;
SLEEP;
STRUCTURE ACTIVITY RELATION;
SYNTHESIS;
ADMINISTRATION, ORAL;
ANIMALS;
ANTI-ANXIETY AGENTS;
BENZIMIDAZOLES;
CEREBRAL CORTEX;
CONFLICT (PSYCHOLOGY);
HUMANS;
INHIBITORY CONCENTRATION 50;
MICE;
PROTEIN BINDING;
PYRIDINES;
RATS;
RECEPTORS, GABA-A;
SEIZURES;
SLEEP;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0037009249
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(02)00463-8 Document Type: Article |
Times cited : (40)
|
References (13)
|